journal article·2020-12

Kinetics of Drug Release via Nicardipine Hydrochloride‐loaded Carboxymethyl Cellulose/Poly(D,L‐lactic‐co‐glycolic acid) Nanocarriers Using a Contemporary Emulsion Process

Nopparuj Soomherun, Narumol Kreua‐ongarjnukool, Saowapa Thumsing Niyomthai, Sorayouth Chumnanvej

ChemNanoMat· Volume 6· Issue 12
Publisher page

Abstract

Abstract A contemporary synthesis of polymeric nanocarriers based on drug delivery systems was employed using a water in oil in water (W1/O/W2) double emulsion process to develop nicardipine hydrochloride‐loaded carboxymethyl cellulose/poly(D,L‐lactic‐co‐glycolic acid) (NCH‐CMC/PLGA) nanocarriers. The optimal synthesis of the nanocarriers was studied, including polymer amount, cross‐linker concentration, and emulsifier concentration. The synthesized nanocarriers were smaller than ∼169 nm and showed a drug encapsulation of more than 80% and a yield of 51% to 73%. The NCH‐CMC/PLGA nanocarriers presented good stability in aqueous dispersion for 10 days. Controlled drug release from the nanocarriers was slow and continuous for up to 16 days. The nanocarriers protected the drug against degradation and maintained therapeutic drug concentrations. In addition, the transport of drug release was studied via five conventional mathematical modelings such as Zero‐order model, First‐order model, Hixson‐Crowell model, Higuchi model, and Korsmeyer‐Peppas model. The Korsmeyer‐Peppas model was fitted to achieve mathematical modeling for the optimized formulation of nanocarriers. Moreover, significant cytocompatibility was observed at all tested doses of NCH‐CMC/PLGA nanocarriers. The NCH‐CMC/PLGA nanocarriers could be an effective drug delivery agent for calcium channel blockers.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Industrial Chemistry Faculty of Applied Science King Mongkut's University of Technology North Bangkok Bangkok Thailand 1518 Pracharat 1 Road, Wongsawang, Bangsue Bangkok 10800

Surgery Department Faculty of Medicine Ramathibodi Hospital Mahidol University, Bangkok Thailand 270 Thanon Rama VI, Thung Phaya Thai, Ratchathewi Bangkok 10400

References (63)

Show source-provided references
1. 10.1002/cnma.20200022910.1002/cnma.202000229 ↗
2. 10.1155/2019/370251810.1155/2019/3702518 ↗
3. 10.1002/app.4722710.1002/app.47227 ↗
4. 10.1021/nn900002m10.1021/nn900002m ↗
5. 10.1016/j.nano.2011.03.00810.1016/j.nano.2011.03.008 ↗
6. 10.1016/j.nano.2011.05.01610.1016/j.nano.2011.05.016 ↗
7. 10.1016/j.jsps.2016.04.01010.1016/j.jsps.2016.04.010 ↗
8. 10.1016/j.jconrel.2017.04.00310.1016/j.jconrel.2017.04.003 ↗
9. 10.1007/s11095-006-0284-810.1007/s11095-006-0284-8 ↗
10. Asem H. · 2018 · 31510.1021/bk-2018-1296.ch016 ↗
11. 10.1155/2013/46249110.1155/2013/462491 ↗
12. Alahamd Y. · Calcium Channel Blockers, New Insight Cereb. Dis. Updated Compr. Rev. · 2020 · 1
13. 10.1016/S0168-3659(02)00465-010.1016/S0168-3659(02)00465-0 ↗
14. 10.1080/02652049928901310.1080/026520499289013 ↗
15. 10.1021/la200552k10.1021/la200552k ↗
16. 10.1038/clpt.1990.5810.1038/clpt.1990.58 ↗
17. 10.1002/cnma.20200017510.1002/cnma.202000175 ↗
18. 10.1002/app.4016810.1002/app.40168 ↗
19. 10.1002/app.4871010.1002/app.48710 ↗
20. 10.1080/17425247.2019.165171610.1080/17425247.2019.1651716 ↗
21. 10.1021/acsbiomaterials.8b0055210.1021/acsbiomaterials.8b00552 ↗
22. 10.1002/cnma.20190051710.1002/cnma.201900517 ↗
23. 10.1155/2017/174376510.1155/2017/1743765 ↗
24. 10.1016/j.foodhyd.2008.05.00710.1016/j.foodhyd.2008.05.007 ↗
25. 10.1021/acsami.7b1071610.1021/acsami.7b10716 ↗
26. 10.1186/1423-0127-16-6510.1186/1423-0127-16-65 ↗
27. 10.1016/j.msec.2016.07.06010.1016/j.msec.2016.07.060 ↗
28. 10.1016/S0939-6411(00)00112-010.1016/S0939-6411(00)00112-0 ↗
29. 10.1016/j.jbiosc.2014.10.02610.1016/j.jbiosc.2014.10.026 ↗
30. 10.1016/j.foodhyd.2016.12.03410.1016/j.foodhyd.2016.12.034 ↗
31. 10.1021/acsami.5b0509310.1021/acsami.5b05093 ↗
32. Azadi S. · J. Appl. Pharmacol. · 2017 · 7
33. Gouda R. · J. Dev. Drugs. · 2017 · 6 · 1000171
34. 10.1016/j.ultsonch.2013.11.00610.1016/j.ultsonch.2013.11.006 ↗
35. 10.1021/bm800377w10.1021/bm800377w ↗
36. C. B. McFarlane A. B. Selkirk M. J. Dey (EKR Therapeutics Inc Roche Holdings Inc) US5164405 A 1992.
37. 10.1016/j.ijbiomac.2016.08.07210.1016/j.ijbiomac.2016.08.072 ↗
38. 10.1016/j.ijbiomac.2018.06.14210.1016/j.ijbiomac.2018.06.142 ↗
39. 10.3390/polym303137710.3390/polym3031377 ↗
40. 10.3390/ijms1503364010.3390/ijms15033640 ↗
41. Wang C. · Nanomaterials. · 2019 · 9 · nano9020145
42. 10.1002/app.4953110.1002/app.49531 ↗
43. 10.1007/s00396-008-1882-210.1007/s00396-008-1882-2 ↗
44. 10.1016/j.ijbiomac.2017.08.12410.1016/j.ijbiomac.2017.08.124 ↗
45. 10.1155/2016/189241210.1155/2016/1892412 ↗
46. 10.1039/c3ay41570h10.1039/c3ay41570h ↗
47. 10.1016/j.biomaterials.2012.09.02310.1016/j.biomaterials.2012.09.023 ↗
48. 10.1016/S0169-409X(02)00228-410.1016/S0169-409X(02)00228-4 ↗
49. 10.1023/A:101608510888910.1023/A:1016085108889 ↗
50. 10.1016/B978-0-323-39040-8.00022-510.1016/B978-0-323-39040-8.00022-5 ↗
51. 10.1016/j.jddst.2019.04.03110.1016/j.jddst.2019.04.031 ↗
52. 10.1016/j.forsciint.2004.11.01410.1016/j.forsciint.2004.11.014 ↗
53. 10.1002/app.4952110.1002/app.49521 ↗
54. 10.1021/ie50260a01810.1021/ie50260a018 ↗
55. Higuchi T. · J. Pharm. Sci. · 1961 · 50
56. 10.1002/jps.260052121010.1002/jps.2600521210 ↗
57. 10.1016/0378-5173(83)90064-910.1016/0378-5173(83)90064-9 ↗
58. Dash S. · Acta Pol. Pharm. · 2010 · 67 · 217
59. 10.5607/en.2015.24.3.23510.5607/en.2015.24.3.235 ↗
60. 10.1089/wound.2013.051710.1089/wound.2013.0517 ↗
61. 10.1016/j.ijpharm.2006.03.04610.1016/j.ijpharm.2006.03.046 ↗
62. 10.2147/IJN.S20413410.2147/IJN.S204134 ↗
63. 10.1142/S0219581X1850043610.1142/S0219581X18500436 ↗